Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Revenue Breakdown and Options Chain

Gain deeper insights into company revenues with a detailed analysis of revenue sources.
Explore the updated Options feature, providing in-depth data, and a 3D viewing option.

Last Close
Mar 28 01:32PM ET
4.14
Dollar change
+0.44
Percentage change
11.89
%
IndexRUT P/E- EPS (ttm)-1.97 Insider Own27.14% Shs Outstand66.21M Perf Week23.95%
Market Cap275.23M Forward P/E- EPS next Y-1.24 Insider Trans3.12% Shs Float48.44M Perf Month61.09%
Income-126.61M PEG- EPS next Q-0.42 Inst Own66.85% Short Float2.62% Perf Quarter126.23%
Sales5.90M P/S46.65 EPS this Y21.73% Inst Trans0.85% Short Ratio4.31 Perf Half Y9.81%
Book/sh3.07 P/B1.35 EPS next Y19.40% ROA-33.72% Short Interest1.27M Perf Year-13.57%
Cash/sh3.98 P/C1.04 EPS next 5Y- ROE-52.14% 52W Range0.86 - 6.98 Perf YTD150.91%
Dividend Est.- P/FCF- EPS past 5Y-20.44% ROI-43.23% 52W High-40.69% Beta2.76
Dividend TTM- Quick Ratio6.83 Sales past 5Y-20.00% Gross Margin10.86% 52W Low381.40% ATR (14)0.29
Dividend Ex-Date- Current Ratio6.83 EPS Y/Y TTM16.45% Oper. Margin-2227.95% RSI (14)76.75 Volatility8.69% 9.81%
Employees174 Debt/Eq0.48 Sales Y/Y TTM- Profit Margin-2144.51% Recom2.00 Target Price7.25
Option/ShortYes / Yes LT Debt/Eq0.44 EPS Q/Q2.36% Payout- Rel Volume1.41 Prev Close3.70
Sales Surprise128.29% EPS Surprise-14.97% Sales Q/Q- EarningsMar 06 AMC Avg Volume294.55K Price4.14
SMA2035.21% SMA5072.35% SMA20033.40% Trades Volume267,004 Change11.89%
Date Action Analyst Rating Change Price Target Change
Oct-19-23Downgrade TD Cowen Outperform → Market Perform
Nov-08-22Initiated Canaccord Genuity Buy $9
Dec-14-21Downgrade William Blair Outperform → Mkt Perform
Jun-08-21Initiated JMP Securities Mkt Outperform $40
Feb-24-21Initiated William Blair Outperform
Feb-18-21Initiated Needham Buy $50
Jul-07-20Initiated Wedbush Outperform $31
Jul-07-20Initiated JP Morgan Overweight $28
Jul-07-20Initiated Jefferies Buy $38
Jul-07-20Initiated Cowen Outperform
Mar-08-24 04:32AM
Mar-06-24 10:52PM
05:40PM
04:20PM
Feb-27-24 06:59AM
04:05PM Loading…
Jan-03-24 04:05PM
Dec-06-23 03:05AM
Nov-29-23 08:41AM
06:59AM
Nov-09-23 04:15PM
Oct-26-23 06:59AM
Oct-18-23 06:59AM
Sep-19-23 07:30AM
Aug-03-23 08:49AM
07:30AM
07:05PM Loading…
Aug-02-23 07:05PM
04:15PM
May-31-23 07:30AM
May-10-23 06:05PM
04:15PM
May-09-23 04:15PM
Apr-11-23 07:30AM
Apr-10-23 09:40AM
Apr-05-23 07:30AM
Mar-24-23 03:02PM
Mar-23-23 10:43AM
07:29AM
07:00AM
Mar-21-23 04:15PM
Feb-27-23 07:30AM
07:18AM Loading…
Feb-24-23 07:18AM
Feb-23-23 04:28PM
Jan-03-23 04:30PM
Dec-05-22 09:55AM
Nov-17-22 09:55AM
Nov-03-22 04:15PM
Nov-01-22 08:07AM
Sep-22-22 07:30AM
Sep-20-22 07:30AM
Sep-17-22 08:12AM
Aug-04-22 05:45PM
04:15PM
Aug-02-22 04:15PM
Jul-18-22 07:30AM
Jul-11-22 09:55AM
Jun-21-22 08:30AM
Jun-02-22 07:30AM
May-25-22 06:37AM
May-05-22 07:05PM
04:15PM
Apr-05-22 07:30AM
Mar-25-22 12:00PM
10:00AM
Mar-02-22 07:30AM
Feb-24-22 04:20PM
Feb-10-22 07:30AM
Jan-05-22 07:30AM
Dec-28-21 07:37PM
Dec-19-21 09:37PM
Dec-16-21 11:02PM
06:38PM
07:01AM
Dec-14-21 06:30AM
12:38AM
Nov-10-21 04:20PM
Oct-22-21 07:30AM
Oct-21-21 04:05PM
Oct-15-21 07:30AM
Sep-30-21 11:12AM
Sep-17-21 08:34AM
Aug-11-21 04:20PM
Aug-03-21 07:30AM
Jul-14-21 07:30AM
Jul-08-21 07:30AM
Jun-19-21 05:55AM
Jun-09-21 07:30AM
May-27-21 07:30AM
May-12-21 04:20PM
Apr-27-21 04:35PM
Apr-08-21 07:30AM
Mar-21-21 05:20AM
Mar-18-21 08:00AM
Mar-01-21 08:53AM
Feb-18-21 10:02AM
07:30AM
Jan-13-21 11:29PM
Jan-11-21 05:43PM
Jan-06-21 09:24PM
Jan-05-21 08:44AM
06:30AM
Jan-04-21 06:30AM
Dec-13-20 03:52AM
Dec-02-20 11:34PM
Nov-10-20 06:30AM
Oct-31-20 08:00AM
Oct-05-20 06:30AM
Sep-24-20 06:30AM
Sep-14-20 10:59AM
Aug-11-20 06:30AM
Aug-05-20 06:30AM
Generation Bio Co. is a genetic medicine company, which focuses on creating a new class of gene therapy to provide durable and redosable treatment for patients suffering from both rare and prevalent diseases. Its non-viral platform incorporates a proprietary high-capacity DNA construct called closed-ended DNA, or ceDNA, a novel cell-targeted lipid nanoparticle delivery system, or ctLNP, and an established, scalable capsid-free manufacturing process. The company was founded by Mark D. Angelino, Jason P. Rhodes, and Robert M. Kotin in 2016 and is headquartered in Cambridge, MA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Samayoa PhillipCHIEF STRATEGY OFFICERJan 02 '24Sale1.622,4453,961107,256Jan 03 04:35 PM
Paone AntoinetteCHIEF OPERATING OFFICERJan 02 '24Sale1.622,4453,9615,828Jan 03 04:35 PM
Appelhans DannielleDirectorDec 08 '23Buy1.797,36313,1807,363Dec 11 04:30 PM
Appelhans DannielleDirectorDec 08 '23Buy1.826371,15912,637Dec 11 04:30 PM
Rowland Charles A JrDirectorDec 04 '23Buy1.50150,000225,000534,757Dec 05 04:30 PM
Appelhans DannielleDirectorDec 04 '23Buy1.5012,00018,00012,000Dec 06 04:30 PM
Rowland Charles A JrDirectorDec 01 '23Buy1.31192,960252,778384,757Dec 05 04:30 PM
Nicholson Donald WilliamDirectorDec 01 '23Buy1.44100,000144,000213,576Dec 05 04:30 PM
Quinn Anthony G.DirectorDec 01 '23Buy1.4188,495124,77888,495Dec 05 04:30 PM
Paone AntoinetteCHIEF OPERATING OFFICERAug 23 '23Sale4.933,11615,3622,914Aug 25 04:35 PM
Samayoa PhillipCHIEF STRATEGY OFFICERJul 03 '23Sale5.293,11616,484101,428Jul 05 04:35 PM
Paone AntoinetteCHIEF OPERATING OFFICERApr 25 '23Sale4.612,91413,4340Apr 26 04:16 PM